Key facts
- Miach Orthopaedics’s last known valuation is $107.0M (Apr 2024).
- It has raised $100.2M across 4 recorded rounds; the latest was Early Stage VC ($6.5M) in May 2026.
- Notable investors include SV Health Investors, NFL Players Association, Amzak Health, Aperture Venture Partners, Endeavour Vision — 9 tracked in total.
- Miach Orthopaedics has filed 2 Form Ds with the SEC since 2023, most recently Apr 2024 ($20.0M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Miach Orthopaedics
Funding rounds
4 roundsAbout Miach Orthopaedics
Developer of bio-engineered surgical implants designed to facilitate new tissue growth and also aid in connective tissue repair. The company's implants specialize in viable alternatives to conventional ACL reconstruction for patients who have sustained any kind of leg injury, enabling surgeons to perform surgery to restore normal anatomy and function of the knee.
- Sector
- Healthcare
- HQ
- Westborough, MA, United States
- Founded
- 2016
- Employees
- 46
- Website
- miachortho.com/
- Ownership
- Privately Held (backing)
Miach Orthopaedics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Miach Orthopaedics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Miach Orthopaedics in its N-PORT filings yet. We sweep new filings monthly.